國立虎尾科技大學 |

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection/ Naseer Ahmed.
作者:	Ahmed, Naseer,
出版者:	London :Academic Press, an imprint of Elsevier, : 2019.,
面頁冊數:	1 online resource :ill., map :
標題:	MEDICAL - Internal Medicine. -
電子資源:	https://www.sciencedirect.com/science/book/9780128180235
ISBN:	9780128182536 (electronic bk.)

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection
Ahmed, Naseer,

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection[electronic resource] /Naseer Ahmed. - London :Academic Press, an imprint of Elsevier,2019. - 1 online resource :ill., map

Includes bibliographical references and index.

Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide aconcise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge toclinical trials for cardioprotection.

ISBN: 9780128182536 (electronic bk.)Subjects--Topical Terms:

862781
MEDICAL
--Internal Medicine.Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: RB144.5

Dewey Class. No.: 616.1/3

National Library of Medicine Call No.: 2019 F-778

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection
LDR:01946cam a2200277 a 4500 001 1043173
006 m o d
007 cr cnu|||unuuu
008 211216s2019 enkab gob 001 0 eng d
020 $a 9780128182536 (electronic bk.)
020 $a 0128182539 (electronic bk.)
020 $a 9780128180235
020 $a 0128180234
035 $a (OCoLC)1103605858
035 $a on1103605858
040 $a N$T $b eng $c N$T $d N$T $d EBLCP $d OPELS $d UKMGB $d OCLCF $d UKAHL $d OCLCQ $d ERF $d LVT $d UX1 $d VT2 $d OCLCO $d OCLCA
041 0 $a eng
050 4 $a RB144.5
060 0 0 $a 2019 F-778
060 1 0 $a WG 282
082 0 4 $a 616.1/3 $2 23
100 1 $a Ahmed, Naseer, $e author. $3 1344234
245 1 0 $a Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection $h [electronic resource] / $c Naseer Ahmed.
260 $a London : $b Academic Press, an imprint of Elsevier, $c 2019.
300 $a 1 online resource : $b ill., map
504 $a Includes bibliographical references and index.
520 $a Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide aconcise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge toclinical trials for cardioprotection.
650 7 $a MEDICAL $x Internal Medicine. $2 bisacsh $3 862781
650 7 $a MEDICAL $x Evidence-Based Medicine. $2 bisacsh $3 862780
650 7 $a MEDICAL $x Diseases. $2 bisacsh $3 862500
650 7 $a MEDICAL $x Clinical Medicine. $2 bisacsh $3 812408
650 7 $a HEALTH & FITNESS $x Diseases $x General. $2 bisacsh $3 862499
650 2 2 $a Myocardial Ischemia. $3 962592
650 2 2 $a Fingolimod Hydrochloride $x therapeutic use. $3 1344237
650 1 2 $a Myocardial Reperfusion Injury $x physiopathology. $3 1344236
650 0 $a Immunosuppressive agents. $3 782623
650 0 $a Ischemia. $3 792106
650 0 $a Reperfusion injury $x Pathophysiology. $3 1344235
655 0 $a Electronic books. $2 local $3 554714
856 4 0 $u https://www.sciencedirect.com/science/book/9780128180235